Pancreatic beta-cell ATP-sensitive potassium channels — Drug Target

All drugs that target Pancreatic beta-cell ATP-sensitive potassium channels — marketed and clinical-stage. Includes 1 drug classes acting on this target.

Drug classes

Sulfonylurea

Phase 2 pipeline (1)

• Diabeton 60 MR · Servier Affaires Médicales · Sulfonylurea · Diabetes
  Diabeton 60 MR is a sustained-release formulation that provides prolonged glucose-lowering effects by inhibiting glucagon-like peptide-1 (GLP-1) degradation.